EDUCATION AND TRAINING

College

Séminaire de Sherbrooke, Quebec, Canada, 1994-95, D.E.C. Health Sciences

Medical school

Sherbrooke University, Quebec, Canada, 1995-2000, M.D.

Residency

Mayo Clinic, Rochester, MN, 2002-05 (Internal Medicine)

Fellowship

Creighton University, Omaha, NE, 2005-07 (Allergy/Immunology)

EMPLOYMENT

• Allergy, Asthma & Immunology Associates, P.C. (July 2007-present)

HOSPITAL PRIVILEGES:

• Bryan Health
• St. Elizabeth Regional Medical Center

ACADEMIC APPOINTMENTS

• Chair, Division of Allergy & Asthma, Bryan Health, 2011-present
• Adjunct faculty, Department of Tuberculosis and Respiratory Diseases, Christian Medical College, 2011-present
• Instructor, Lincoln Family Practice, 2007-present
• Instructor, Union College, 2007-present

LICENSURE

State of Nebraska #23892

BOARD CERTIFICATION

• American Board of Internal Medicine (2005-2015)
• American Board of Allergy and Immunology (2007-2017)

HONORS AND AWARDS

• 1995 Governor’s General Academic Medal (Canada)
• 1997 Networks of Centres of Excellence research scholarship (Canada)
• 2005 Chrysalis Project mentor
• 2006 CIS/AAAAI School on Hypersensitivity and Allergic Diseases award recipient
• 2007 Pulmonary & Allergy Fellows’ Symposia award recipient
• 2010 New Allergist/Immunologist Assembly mentor
• 2013 Clinic with a Heart Community Partner Award

PROFESSIONAL AFFILIATIONS

• American Academy of Allergy, Asthma and Immunology, fellow
• American College of Allergy, Asthma & Immunology, fellow
• AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy Committee, member
• AAAAI Health Informatics, Technology & Education Committee, member
• AAAAI Practice Management Committee, member
• Nebraska Medical Association, member

PROFESSIONAL ACTIVITIES

• Adjunct faculty for the Diploma in Allergy & Asthma (DAA) course at Christian Medical College (Vellore, India)
• Instructor in Allergy/Immunology at Lincoln Family Medicine Center (Nebraska)
• Instructor in Allergy/Immunology at Union College (Nebraska)

JOURNAL REVIEW

• Reviewer, Respiratory Research (2010-present)

EDITORIAL BOARD

• Editorial Board, Journal of Allergy & Therapy (2010-present)

CLINICAL RESEARCH STUDIES

2005-2006

1. Dynavax Technologies: A Phase IIb, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy, Safety, Tolerability, and Immunogenicity in Ragweed Allergic Adults following Subcutaneous Administration of Dynavax Amb a 1 Immunostimulatory Oligodeoxyribonucleotide Conjugate (AIC), Sub-Investigator.

2. Dynavax Technologies: A Phase III, Non-Pivotal, Double-Blind, Randomized Study of the Efficacy, Safety and Tolerability of Subcutaneously Administered Dynavax Amb a 1 Immunostimulatory Oligodeoxyribonucleotide Conjugate (AIC) Plus Antihistamine and Decongestant versus Antihistamine and Decongestant Alone in Ragweed Allergic Children, Sub-Investigator.

3. Capnia: Feasibility Study to Evaluate the Efficacy of Carbon Dioxide Gas (CO2) for the Relief of Symptoms Associated with Seasonal Allergic Rhinitis, Sub-Investigator.

4. Astellas Pharma, Inc: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects with Persistent Asthma, Sub-Investigator.

5. Schering-Plough: The Effects of Mometasone DPI on Markers of Airway Inflammation, Sub-Investigator.

6. Novartis Pharmaceuticals: A 26-Week, Randomized, Double-Blind, Parallel-Group Placebo-Controlled, Multi-Center Study to Evaluate the Effect of Xolair (omalizumab) On Improving the Tolerability of Specific Immunotherapy in Patients with Persistent Allergic Asthma, Sub-Investigator.

7. Dynavax Technologies: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Subcutaneously Administered TOLAMBA in Ragweed-Allergic Adults, Sub-Investigator.

8. Pharmaxis: A Phase III Multicenter Study to Demonstrate the Sensitivity of Aridol (Mannitol) Challenges as Compared with Methacholine Challenge to Predict Bronchial Hyperresponsiveness as Manifested By a Positive Exercise Challenge in Subjects Presenting with Signs and Symptoms Suggestive of Asthma but Without a Definitive Diagnosis, Sub-Investigator.

9. Aperon: Monitoring the Fractional Concentration of Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Before and After Steroid Therapy Using the Aperon NO Analyzer, Sub-Investigator.

10. ZLB Behring: Human Pasteurized C1 Esterase Inhibitor Concentrate In Subjects With Congenital C1-INH Deficiency And Acute Abdominal or Facial HAE Attacks, Sub-Investigator.

11. Novartis Pharmaceuticals: The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils, Sub-Investigator.

12. Genentech: Effects of Omalizumab (Xolair) on Airway Hyperresponsiveness, Sub-Investigator.

13. GlaxoSmithKline: A Multicenter, Randomized, Double Blind Triple Dummy, Placebo-Controlled Parallel Group, Four Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200 mcg QD versus Montelukast 10 mg QD in Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Who Are Receiving Advair Diskus 100/50 mcg BID or Placebo BID, Sub-Investigator.

2007

14. Genentech: A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma (EXCELS), Sub-Investigator.

15. Sanofi-Aventis: Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR), Sub-Investigator.

16. Schering-Plough: A Study of the Equivalent Effectiveness of 400 Mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics, Sub-Investigator.

17. Meda Pharmaceuticals: A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies, Sub-Investigator.

18. GlaxoSmithKline: Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine, Sub-Investigator.

19. GlaxoSmithKline: A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma, Sub-Investigator.

20. GlaxoSmithKline: A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis, Sub-Investigator.

2008

21. Meda Pharmaceuticals: A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies, Sub-Investigator.

22. Alcon Research: Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients, Principal Investigator.

23. Greer Laboratories: Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies, Sub-Investigator.

NATIONAL MEETINGS

Poster presentations

1. Mehta V, Kushniruk A, Gauthier S, Richard Y, Deland E, Veilleux M, Grant A. The efficient use of information by the professional team of a clinical unit to obtain consensus for practice change: a study forming part of the Autocontrol Project. Presented at the HEALNet Annual Meeting, Toronto, ON, Nov. 13-15, 1997.

2. V. Mehta, A. Madaan, C. K. Kim, J. B. Hagan. No evidence of increased sputum eosinophilia in treated asthma patients with gastroesophageal reflux. Presented at the Annual Meeting of the AAAAI, San Francisco, CA, Mar.

3. Mehta V, Stump, Craig. Resistant diabetes mellitus in a woman with systemic lupus erythematous. Presented at the American College of Physicians Annual Session, New Orleans, LA, Apr. 22-24, 2004.

4. V. Mehta, T. Kobayashi, H. Kita. Effect of fungal antigen exposure on airway allergen sensitization. Presented at the Annual Meeting of the AAAAI, San Antonio, TX, Mar. 18-22, 2005.

5. V. Mehta, J. B. Hagan. Chronic rhinosinusitis in asthmatics is related to sputum eosinophilia. Presented at the Annual International Conference of the American Thoracic Society, San Diego, CA, May 21-25, 2005.

6. V. Mehta, M.A. Park. Successful carboplatin desensitization in a patient with a previous history of carboplatin hypersensitivity. Presented at the Annual Meeting of the ACAAI, Anaheim, Nov 4-9, 2005.

7. V. Mehta, K. Parks, A. Bewtra. Concomitant histopathological findings of allergic fungal sinusitis and fungal ball in the same sinus: a rare case report. Presented at the Annual Meeting of the AAAAI, Miami, FL, Mar. 3-7, 2006.

8. T. Kobayashi, K. Iijima, S. Radhakrishnan, V. Mehta, R. Vassallo, L. R. Pease, H. Kita. Innate immune response to an environmental fungus, alternaria, facilitates Th2-type airway sensitization to a bystander antigen. Presented at the Annual Meeting of the AAAAI, Miami, FL, Mar. 3-7, 2006.

9. J.B. Hagan, V. Mehta, H. Kita. Airway wall thickening is associated with sinus mucosal thickening. Presented at the Annual Meeting of the American Thoracic Society, San Diego, CA, May 19-24, 2006.

10. V. Mehta, R. Townley. Hypereosinophilia associated with CD30+ anaplastic large-cell lymphoma: a rare case report. Presented at the Annual Meeting for the ACAAI, Philadelphia, PA, Nov 9-15, 2006.

11. V. Mehta, B. Moore, A. Bewtra, D.K. Agrawal. A potential role of inhibitor of apoptosis proteins in the regulation of eosinophil apoptosis in allergic disease. Presented at the Annual Meeting of the AAAAI, San Diego, CA, Feb. 23-27, 2007.

12. F.A. Romero, V. Mehta, J.R Stokes, T.B. Casale. The effects of mometasone DPI on markers of airway inflammation. Presented at the Annual Meeting of the AAAAI, San Diego, CA, Feb. 23-27, 2007.

Oral Presentations

1. Difficult Cases – Atopy in Older Adults. Presented at the Annual Meeting of the AAAAI, Orlando, FL, Mar. 2-6, 2012.

2. Difficult Situations in Practice Management – Hiring and Firing. Presented at the Annual Meeting of the AAAAI, Orlando, FL, Mar. 2-6, 2012.

3. Venom Immunotherapy. Presented at the Insect Allergy Symposium, Entomological Society of America (North Central Branch) Annual Meeting, Lincoln, NE, Jun. 3-6, 2012.

PUBLICATIONS

Original articles

1. Mehta V, Kushniruk A, Gauthier S, Richard Y, Grant A. Use of evidence in the process of practice change in a clinical team: a study-forming part of the Autocontrol Project. Int J Med Inf 1998 Aug-Sep; 51(2-3):169-80.

2. Mehta V, Swaroop, VS. 70-year-old woman with rash and muscle weakness. Mayo Clin Proc 2004

3. Mehta V, Mueller PS, Gonzalez-Arriaza HL, Pankratz VS, Rummans TA. Safety of Electroconvulsive Therapy in Patients Receiving Chronic Warfarin Anticoagulation Therapy. Mayo Clin Proc 2004 Nov;79(11):1396-401.

4. Reilkoff, R, Mehta V, Gajic, O. 67-year-old man with fever, back pain and lower extremity weakness. Mayo Clin Proc 2005 Nov; 80(11): 1510-13.

5. Mehta V, Campeau, NG, Kita H, Hagan JB. Blood and sputum eosinophil levels in asthma and their relationship to sinus computed tomographic findings. Mayo Clin Proc 2008 Jun; 83(6): 671-8.

6. Kobayashi T, Iijima K, Radhakrishnan S, Mehta V, Vassallo R, Lawrence CB, Cyong JC, Pease LR, Oguchi K, Kita H. Asthma-related environmental fungus, Alternaria, activates dendritic cells and produces potent Th2 adjuvant activity. J Immunol 2009 Feb; 15;182(4):2502-10.

7. Mehta V, Stokes JR, Berro A, Romero FA, Casale TB. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma. Ann Allergy Asthma

Chapter

Common Office Procedures (Chapter 8). AAAAI Practice Management Resource Guide, American Academy of Asthma, Allergy and Immunology (2012).

COMMUNITY ACTIVITIES

Clinic with a Heart

Provide free care to uninsured patients with suspected allergic disorders.

International Asthma Services

Conduct free asthma camps in India and provide education to local physicians regarding allergic disorders.